InsidersTradesSigma
Total declarations
Companies
▲ Purchases (107 ops.)
▼ Sales (4 ops.)
Insider track record
OtherDisclosed buys
107
Disclosed sells
4
T+90 hit rate
37%
T+90 mean return
+2.1%
Across 60 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Broadwood Partners, L.p.. Officer active across 5 companies, notably Staar Surgical Co. In total, 114 disclosures have been logged. Split: 107 buys · 4 sells. Total volume traded: €101.1m. History available since 27 May 2021. The latest transaction was disclosed on 23 April 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Broadwood Partners, L.p.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations114 total
00Common Stock, no par valueSEC:0000919574-26-002414:1
Canonical exit: 22 Jul 2026 (T+90)
00Common Stock, no par valueSEC:0000919574-26-002414:3
Canonical exit: 23 Jul 2026 (T+90)
00Common Stock, no par valueSEC:0000919574-26-002414:5
Canonical exit: 26 Jul 2026 (T+90)
280,381 shares@ US$3.502548.4% of flowCommon Stock, no par valueSEC:0000919574-26-002414:0
Canonical exit: 22 Jul 2026 (T+90)
38,880 shares@ US$3.52586.8% of flowCommon Stock, no par valueSEC:0000919574-26-002414:2
Canonical exit: 23 Jul 2026 (T+90)
250,923 shares@ US$3.639144.8% of flowCommon Stock, no par valueSEC:0000919574-26-002414:4
Canonical exit: 26 Jul 2026 (T+90)
00Common Stock, no par valueSEC:0000919574-26-002306:1
Canonical exit: 15 Jul 2026 (T+90)
00Common Stock, no par valueSEC:0000919574-26-002306:3
Canonical exit: 16 Jul 2026 (T+90)
00Common Stock, no par valueSEC:0000919574-26-002306:5
Canonical exit: 19 Jul 2026 (T+90)
102,057 shares@ US$3.445713.0% of flowCommon Stock, no par valueSEC:0000919574-26-002306:0
Canonical exit: 15 Jul 2026 (T+90)
40,114 shares@ US$3.57115.3% of flowCommon Stock, no par valueSEC:0000919574-26-002306:2
Canonical exit: 16 Jul 2026 (T+90)
40,690 shares@ US$3.88225.9% of flowCommon Stock, no par valueSEC:0000919574-26-002306:4
Canonical exit: 19 Jul 2026 (T+90)
54,764 shares@ US$17.52171.4% of flowCommon StockSEC:0000919574-26-001617:0
Canonical exit: 9 Jun 2026 (T+90)
521,739 shares@ US$5.7552.4% of flowCommon Stock, no par valueSEC:0000919574-26-000779:0
Canonical exit: 11 May 2026 (T+90)
27,485 shares@ US$22.05340.8% of flowCommon StockSEC:0001213900-26-004132:0
Canonical exit: 9 Apr 2026 (T+90)
00Common StockSEC:0001213900-26-004132:1
Canonical exit: 9 Apr 2026 (T+90)
186,946 shares@ US$21.01115.8% of flowCommon StockSEC:0001213900-26-002643:0
Canonical exit: 6 Apr 2026 (T+90)
309,132 shares@ US$26.416413.2% of flowCommon StockSEC:0001213900-25-113799:0
Canonical exit: 17 Feb 2026 (T+90)
166,527 shares@ US$15.2773.6% of flowCommon StockSEC:0000919574-25-002400:0
Canonical exit: 7 Jul 2025 (T+90)
209,535 shares@ US$16.96685.0% of flowCommon StockSEC:0000919574-25-002317:0
Canonical exit: 2 Jul 2025 (T+90)
22,189 shares@ US$17.45730.6% of flowCommon StockSEC:0000919574-25-002221:0
Canonical exit: 29 Jun 2025 (T+90)
101,633 shares@ US$17.49942.5% of flowCommon StockSEC:0000919574-25-002165:0
Canonical exit: 24 Jun 2025 (T+90)
102,400 shares@ US$17.73972.6% of flowCommon StockSEC:0000919574-25-002112:0
Canonical exit: 19 Jun 2025 (T+90)
34,296 shares@ US$17.44160.9% of flowCommon StockSEC:0000919574-25-002112:2
Canonical exit: 23 Jun 2025 (T+90)
00Common StockSEC:0000919574-25-002112:1
Canonical exit: 19 Jun 2025 (T+90)
25 of 114 declarations
About Broadwood Partners, L.p.
BROADWOOD PARTNERS, L.P. has filed 114 filings in total. Across the covered sample of recent filings, from 2016-01-04 to 2026-04-27, buy amounts are EUR 82495698 and sell amounts are EUR 18616048, with filings involving Staar Surgical Co, Insight Molecular Diagnostics Inc., OncoCyte Corp, Lineage Cell Therapeutics, Inc. and BIOTIME INC.
